Clinical Trial Update: Volume Replacement With Albumin in Severe Sepsis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating volume replacement with albumin in severe sepsis and septic shock has completed. This document notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Albumin

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: COMPLETED